Haleon plc Stock (GB00BMX86B70): Analyst Upgrade and US Market Relevance for Retail Investors
Haleon plc stock has received an analyst upgrade with a revised price target, highlighting the company's growth in consumer health and its strategic positioning, particularly in the US market. The upgrade reflects confidence in Haleon's diversified product lineup, innovation focus, and commitment to sustainability, all of which contribute to stable revenue growth. For US retail investors, Haleon offers exposure to a leading consumer health company with strong brand recognition and potential for continued growth.
APR 20·TipRanks▲
Haleon Cancels 8.7 Million Shares Under Ongoing Buyback Programme
Haleon PLC has cancelled 8.74 million ordinary shares as part of its ongoing share buyback programme, which commenced in March 2026. This action adjusts the company's registered share capital and reduces the number of shares with voting rights. An analyst has rated Haleon (GB:HLN) stock as a Buy with a £450.00 price target, while TipRanks’ AI Analyst, Spark, deems it Neutral due to strong financials balanced by technical momentum and valuation.
MAR 29·The Globe and Mail▲
Barclays Remains a Buy on Haleon PLC (HLN)
Barclays has reiterated a Buy rating on Haleon PLC (HLN) with analyst Warren Ackerman maintaining the recommendation. The company's shares closed at p366.90, and the analyst consensus suggests a Moderate Buy with a price target representing a 16.23% upside. Haleon reported a quarterly revenue of p2.74 billion and a net profit of p403 million for the quarter ending June 30.
